Call for Papers: JMIR Theme Issue "Cybersecurity in Healthcare and Biomedical Research"

JMIR Special Issue on Cybersecurity in Medicine and Biomedical Research - Call for Papers

Call for Papers

JMIR is inviting submissions for a special issue of the journal that will be dedicated to the topic of Cybersecurity in Healthcare and Biomedical Research (Guest Editors: Perakslis and Stanley)

Photo credit: datacorpltd via / CC BY-NC

Cybersecurity has become a dominant topic in medicine, biomedical research and everyday life but specific cyber threats and cyber resilience strategies are not well understood.  Further, technology vendors and the lay press are producing massive amounts of online content that can be difficult to interpret and apply.  Concurrently, digital medicine continues to grow and evolve at rapid pace and many struggle with the benefit risk calculations that digital health and cyber security present.  There is a great unmet need for high quality, peer-reviewed content on biomedical cyber security that addresses the specific challenges and opportunities of digital medicine.

We are seeking papers on the following 7 topics:

1. Cybersecurity in Clinical Systems

2. Cybersecurity in mHealth

3. Next-generation Patient Identity

4. Datasecurity in Rare Diseases and Open Science

5. Cybersecurity in Global Health

6. Security and Privacy in Wearable Clinical Devices

7. Open topic healthcare/biomedical cybersecurity

Important Dates 

            • Submission Deadline: January 15th, 2018
            • Notification of initial decision to authors: approx.. March 15th, 2018
            • Final version of Paper Due: 8 weeks after initial decision (approx. May 15th, 2018)
            • Special Issue Publication Date: starting June 2018

All deadlines are 11:59pm EST.

Submission of Papers

You are invited to submit a full length manuscript of no more than 7,500 words.

Submitted papers should report new and original results that are unpublished elsewhere. Please prepare your manuscript with the template file and guidelines found at

Manuscripts should be sent through the online system at .

In submission step 1, authors must choose the section “Special issue on Cybersecurity” (Guest Editors: Perakslis and Stanley) (see also How do I submit to a theme issue?).

All submitted manuscripts will undergo a full peer review process consistent with usual rigorous editorial criteria for JMIR. Accepted papers will be published in JMIR, or may be transferred to JMIR Public Health and Surveillance, JMIR Medical Informatics, JMIR Mental Health, JMIR Human Factors, JMIR Res Protoc or another JMIR sister journal, according to focus and impact of the paper. All papers will appear together in an e-collection (theme issue) guest edited by the academics listed below. Papers rejected for the theme issue may still be considered for regular issues.

For this theme issue, Article Processing Fees are discounted by 20% (saves up to $500).

Guest Editors:

Eric Perakslis (Twitter: @eperakslis), Visiting Scientist in Biomedical Informatics at Harvard Medical School,

Eric Perakslis is a research, informatics, technology and R&D leader with more than 19 years of direct experience in information technology, informatics, research, healthcare, government regulation, biotechnology and pharmaceuticals discovery and development.

He received his PhD in Chemical and Biochemical Engineering from Drexel University. Following a stint with ArQule, Inc., he joined the Johnson and Johnson companies, serving first as Director of Drug Discovery Global Information Solutions, NA  at RWJ Pharmaceutical Research and progressing to Vice President R&D Informatics at Centocor and Member of the J&J Corporate Office of Science and Technology and ultimately to Sr Vice President, CIO at J&J Pharma R&D and Head of Translational Informatics at J&J Corporate Office of Science and Development. Perakslis became CIO and Chief Scientist (Informatics) at the FDA in 2011 before moving to HMS to serve as Executive Director at the Center for Biomedical Informatics. He currently is Senior VP, R&D Informatics at Takeda Pharmaceuticals International Inc. in Cambridge, MA.

Martin Stanley, Branch Chief, Cybersecurity Assurance, Federal Network Resilience, U.S. Department of Homeland Security.

Martin Stanley is an Information Security and IT Leader within the Department of Homeland Security’s Office of Cybersecurity and Communications. He is responsible for overseeing the Cybersecurity Assurance practices within the Division of Federal Network Resilience. In this role, Martin has established the Cybersecurity Engineering program which is a priority initiative under the Administration’s Cybersecurity National Action Plan. The Cybersecurity Engineering initiative will strengthen Federal Civilian Government cybersecurity by providing security engineering expertise and assistance to further secure agency systems, networks, and data. Martin came to DHS from the United States Food and Drug Administration where he served as the Division Director of the Division of Technology in the Office of Information Management and led the FDA-wide Information Security Program.Martin Stanley previously served as the Senior Vice President of Architecture at Vonage, the Broadband Phone Company, where he led a groundbreaking nationwide VOIP E-911 implementation. Martin was an early employee at UUNET Technologies, the pioneering Internet Service Provider.Martin maintains a keen interest in public health initiatives and currently serves as a technical advisor to the American Society of Clinical Oncologists (ASCO) for a revolutionary new patient record system which will ensure quality and innovation of care for cancer patients. He recently co-authored “A Cybersecurity Primer for Translational Research” in Science Translational Medicine.